Charte d’Informations Médicales (CIM)
la StopSmokingTherapy® est la solution qu’il vous faut pour arrêter de fumer de manière durable et efficace.
1 - Informations médicales générales relatives à la StopSmokingTherapy®
1.1 . Consultation médicale préalable
Avant l’inscription du patient fumeur au programme de sevrage tabagique StopSmokingTherapy®, nous lui recommandons de consulter son médecin traitant, pour avoir plus de renseignements sur la thérapie et savoir si la période qu’il traverse et son état de santé, sont favorables au sevrage tabagique.
1.2 . NoSmo® ne peut être considéré comme un dispositif médical
Le Support de l’application NoSmo® est développé par des médecins tabacologues, addictologues et psychiatres, spécialisés en sevrage tabagique. Cependant, seule, l’Application ne peut constituer un dispositif médical et n’a pas vocation à remplacer un médecin. Consulter un médecin en plus de l’utilisation de l’application est recommandé. En cas de complications, consultez votre médecin.
1.3. Conformité de la StopSmokingTherapy® aux règlementations de bonnes pratiques médicales
La StopSmokingTherapy® s’appuie sur les travaux de médecins ayant spécifiquement conçu les contenus médicaux de l’App ainsi que la littérature scientifique et médicale de référence dans le domaine et notamment certaines publications de la HAS (Haute Autorité de Santé) pour ce qui est des recommandations de bonnes pratiques pour la prise en charge médicamenteuse et non médicamenteuse du sevrage tabagique (TCC, consultation avec un médecin spécialisé par exemple…).
Plus d’informations :
1.4. La rubrique « Conseils, recommandations et Thérapies Cognitives et Comportementales (TCC) » NoSmo®
Nos conseils, recommandations et notre approche adaptée des Thérapies cognitives et Comportementales (TCC) sont issus de travaux de médecins ayant spécifiquement travaillé sur la StopSmokingTherapy ®.
Plus d’informations sur les données scientifiques sur lesquelles reposent leurs travaux:
-
Spears CA, Hedeker D, Li L, Wu C, Anderson NK, Houchins SC, Vinci C, Hoover DS, Vidrine JI, Cinciripini PM, Waters AJ, Wetter DW. Mechanisms underlying mindfulness-based addiction treatment versus cognitive behavioral therapy and usual care for smoking cessation. J Consult Clin Psychol. 2017 Nov;85(11):1029-1040. doi: 10.1037/ccp0000229. Epub 2017 Jun 26. PMID: 28650195; PMCID: PMC5662477.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662477/pdf/nihms882366.pdf -
Lindson‐Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD006936. DOI: 10.1002/14651858.CD006936.pub3. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006936.pub3/epdf/full
-
Bricker JB, Copeland W, Mull KE, Zeng EY, Watson NL, Akioka KJ, Heffner JL. Single-arm trial of the second version of an acceptance & commitment therapy smartphone application for smoking cessation. Drug Alcohol Depend. 2017 Jan 1;170:37-42. doi: 10.1016/j.drugalcdep.2016.10.029. Epub 2016 Nov 4. PMID: 27870987; PMCID: PMC5183543. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183543/pdf/nihms831156.pdf
-
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD001292. doi: 10.1002/14651858.CD001292.pub3. PMID: 28361496; PMCID: PMC6464359. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001292.pub3/epdf/full
-
Schlam TR, Baker TB. Interventions for tobacco smoking. Annu Rev Clin Psychol. 2013;9:675-702. doi: 10.1146/annurev-clinpsy-050212-185602. Epub 2013 Jan 3. PMID: 23297788; PMCID: PMC5844577. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844577/pdf/nihms905752.pdf
1.5. La rubrique « Bénéfices et économie » NoSmo®
Le calcul des économies réalisées se font en fonction des informations renseignées par le patient, sous sa seule responsabilité. Le prix des cigarettes évoluant d’une année sur l’autre, les montants exprimés sont des approximations désignant un ordre de grandeur. Ces informations sont données exclusivement à titre indicatif et ne constituent pas un engagement. Les Laboratoires EdelweissLab® ne sauraient en aucun cas être tenus responsables, de quelque manière que ce soit de toutes conséquences directes ou indirectes d’une donnée erronée quant aux bénéfices économiques réalisés après l’arrêt du tabac, et ce quelles que soient l’origine ou la cause de cette donnée erronée.
1.6. La rubrique « Bénéfices santé » NoSmo®
Les bénéfices santé qu’un fumeur peut espérer obtenir à l’arrêt du tabac, et qui apparaissent sur l’application et les différents supports numériques NoSmo®, sont issus de la littérature scientifique spécialisée. Il s’agit de données statistiques qui, par nature, sont indicatives de tendances et de probabilités en termes de bénéfices attendus. Chaque sujet étant par nature unique, il est possible que certaines de ses caractéristiques personnelles le distinguent des personnes constituant les échantillons étudiés dans les études. Ainsi ces données sont communiquées à titre informatif et ne sauraient en aucun cas être considérées comme garanties à titre individuel. Les laboratoires EdelweissLab® ne peuvent en aucun cas être tenus responsables de la non occurence ou de l’occurrence différente en nature ou dans le temps chez un ou plusieurs utilisateurs de l’outil numérique NoSmo®, d’un ou plusieurs des bénéfices listés dans cette rubrique.
Plus d’informations sur la littérature scientifique sur laquelle se fondent les éléments communiqués dans la rubrique :
-
Fagerström K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs. 2002;62 Suppl 2:1-9. doi: 10.2165/00003495-200262002-00001. PMID: 12109931.
https://pubmed.ncbi.nlm.nih.gov/12109931/ -
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2817%2930819-X -
Wang R, Jiang Y, Yao C, Zhu M, Zhao Q, Huang L, Wang G, Guan Y, Michael E, Zhao G. Prevalence of tobacco related chronic diseases and its role in smoking cessation among smokers in a rural area of Shanghai, China: a cross sectional study. BMC Public Health. 2019 Jun 13;19(1):753. doi: 10.1186/s12889-019-7110-9. PMID: 31196049; PMCID: PMC6567455.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567455/pdf/12889_2019_Article_7110.pdf -
Samet JM. Smoking cessation: benefits versus risks of using pharmacotherapy to quit. Circulation. 2014 Jan 7;129(1):8-10. doi: 10.1161/CIRCULATIONAHA.113.006928. Epub 2013 Dec 9. PMID: 24323794; PMCID: PMC3917568.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917568/pdf/nihms543883.pdf -
Mannan H, Curtis AJ, Forbes A, Magliano DJ, Lowthian JA, Gambhir M, McNeil JJ. Improvements in life expectancy among Australians due to reductions in smoking: Results from a risk percentiles approach. BMC Public Health. 2016 Jan 26;16:77. doi: 10.1186/s12889-016-2750-5. PMID: 26813029; PMCID: PMC4729127.
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-2750-5 -
Sundberg L, Agahi N, Fritzell J, Fors S. Why is the gender gap in life expectancy decreasing? The impact of age- and cause-specific mortality in Sweden 1997-2014. Int J Public Health. 2018 Jul;63(6):673-681. doi: 10.1007/s00038-018-1097-3. Epub 2018 Apr 13. PMID: 29654335; PMCID: PMC6015620.
https://link.springer.com/article/10.1007/s00038-018-1097-3 -
Bloom EL, Minami H, Brown RA, Strong DR, Riebe D, Abrantes AM. Quality of life after quitting smoking and initiating aerobic exercise. Psychol Health Med. 2017 Oct;22(9):1127-1135. doi: 10.1080/13548506.2017.1282159. Epub 2017 Jan 19. PMID: 28103704; PMCID: PMC5624525.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624525/pdf/nihms899024.pdf -
Ia H, Zack MM, Gottesman II, Thompson WW. Associations of Smoking, Physical Inactivity, Heavy Drinking, and Obesity with Quality-Adjusted Life Expectancy among US Adults with Depression. Value Health. 2018 Mar;21(3):364-371. doi: 10.1016/j.jval.2017.08.002. Epub 2017 Oct 18. PMID: 29566844.
https://www.valueinhealthjournal.com/action/showPdf?pii=S1098-3015%2817%2930335-2
1.7 La rubrique « Motivations » NoSmo®
La rubrique « motivations » est issue de travaux de médecins ayant spécifiquement conçu la StopSmokingTherapy ®. Ils s’inspirent aussi des publications suivantes :
-
Lindson‐Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD006936. DOI: 10.1002/14651858.CD006936.pub3.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006936.pub3/epdf/full -
García-Gómez L, Hernández-Pérez A, Noé-Díaz V, Riesco-Miranda JA, Jiménez-Ruiz C. SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS. Rev Invest Clin. 2019;71(1):7-16. doi: 10.24875/RIC.18002629. PMID: 30810545.
1.8 La rubrique « Causes de rechutes » NoSmo®
La rubrique « causes de rechutes » est issue de travaux de médecins ayant spécifiquement conçu la StopSmokingTherapy®. Ils s’inspirent aussi des publications suivantes :
-
Alboksmaty A, Agaku IT, Odani S, Filippidis FT. Prevalence and determinants of cigarette smoking relapse among US adult smokers: a longitudinal study. BMJ Open. 2019 Nov 25;9(11):e031676. doi: 10.1136/bmjopen-2019-031676. PMID: 31772095; PMCID: PMC6886963.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886963/pdf/bmjopen-2019-031676.pdf -
Yong HH, Borland R, Cummings KM, Partos T. Do predictors of smoking relapse change as a function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia. Addiction. 2018 Jul;113(7):1295-1304. doi: 10.1111/add.14182. Epub 2018 Mar 2. PMID: 29405520; PMCID: PMC5993599.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993599/pdf/nihms940029.pdf -
Quisenberry AJ, Pittman J, Goodwin RD, Bickel WK, D'Urso G, Sheffer CE. Smoking relapse risk is increased among individuals in recovery. Drug Alcohol Depend. 2019 Sep 1;202:93-103. doi: 10.1016/j.drugalcdep.2019.07.001. Epub 2019 Jul 8. PMID: 31325822; PMCID: PMC6685745.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685745/pdf/nihms-1535012.pdf
2 - Bibliographie, ouvrages et littérature scientifique de référence :
Vous trouverez ci-dessous le lien vers l’ensemble des travaux qui ont servi de base scientifique au travail des médecins ayant conçu la StopSmokingTherapy®.
De domaines variés, ils traitent des différentes méthodes de l’arrêt du tabac, des facteurs motivationnels, des thérapies non médicamenteuses recommandées par les hautes autorités de santé, mais aussi du protocole d’abstinence et d’hyperhydratation et des accompagnements numériques d’aide au sevrage.
-
https://www.santemagazine.fr/sante/addictions/tabac/tous-les-benefices-de-larret-du-tabac-867414
-
https://fr.treated.com/blog/benefices-de-larret-de-la-cigarette
-
Spears CA, Hedeker D, Li L, Wu C, Anderson NK, Houchins SC, Vinci C, Hoover DS, Vidrine JI, Cinciripini PM, Waters AJ, Wetter DW. Mechanisms underlying mindfulness-based addiction treatment versus cognitive behavioral therapy and usual care for smoking cessation. J Consult Clin Psychol. 2017 Nov;85(11):1029-1040. doi: 10.1037/ccp0000229. Epub 2017 Jun 26. PMID: 28650195; PMCID: PMC5662477.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662477/pdf/nihms882366.pdf -
Lindson‐Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD006936. DOI: 10.1002/14651858.CD006936.pub3.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006936.pub3/epdf/full -
Bricker JB, Copeland W, Mull KE, Zeng EY, Watson NL, Akioka KJ, Heffner JL. Single-arm trial of the second version of an acceptance & commitment therapy smartphone application for smoking cessation. Drug Alcohol Depend. 2017 Jan 1;170:37-42. doi: 10.1016/j.drugalcdep.2016.10.029. Epub 2016 Nov 4. PMID: 27870987; PMCID: PMC5183543.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5183543/pdf/nihms831156.pdf -
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD001292. doi: 10.1002/14651858.CD001292.pub3. PMID: 28361496; PMCID: PMC6464359.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001292.pub3/epdf/full -
Schlam TR, Baker TB. Interventions for tobacco smoking. Annu Rev Clin Psychol. 2013;9:675-702. doi: 10.1146/annurev-clinpsy-050212-185602. Epub 2013 Jan 3. PMID: 23297788; PMCID: PMC5844577.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844577/pdf/nihms905752.pdf -
Fagerström K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs. 2002;62 Suppl 2:1-9. doi: 10.2165/00003495-200262002-00001. PMID: 12109931.
https://pubmed.ncbi.nlm.nih.gov/12109931/ -
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
https://www.thelancet.com/action/showPdf?pii=S0140-6736%2817%2930819-X -
Wang R, Jiang Y, Yao C, Zhu M, Zhao Q, Huang L, Wang G, Guan Y, Michael E, Zhao G. Prevalence of tobacco related chronic diseases and its role in smoking cessation among smokers in a rural area of Shanghai, China: a cross sectional study. BMC Public Health. 2019 Jun 13;19(1):753. doi: 10.1186/s12889-019-7110-9. PMID: 31196049; PMCID: PMC6567455.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567455/pdf/12889_2019_Article_7110.pdf -
Samet JM. Smoking cessation: benefits versus risks of using pharmacotherapy to quit. Circulation. 2014 Jan 7;129(1):8-10. doi: 10.1161/CIRCULATIONAHA.113.006928. Epub 2013 Dec 9. PMID: 24323794; PMCID: PMC3917568.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917568/pdf/nihms543883.pdf -
Mannan H, Curtis AJ, Forbes A, Magliano DJ, Lowthian JA, Gambhir M, McNeil JJ. Improvements in life expectancy among Australians due to reductions in smoking: Results from a risk percentiles approach. BMC Public Health. 2016 Jan 26;16:77. doi: 10.1186/s12889-016-2750-5. PMID: 26813029; PMCID: PMC4729127.
https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-016-2750-5 -
Sundberg L, Agahi N, Fritzell J, Fors S. Why is the gender gap in life expectancy decreasing? The impact of age- and cause-specific mortality in Sweden 1997-2014. Int J Public Health. 2018 Jul;63(6):673-681. doi: 10.1007/s00038-018-1097-3. Epub 2018 Apr 13. PMID: 29654335; PMCID: PMC6015620.
https://link.springer.com/article/10.1007/s00038-018-1097-3 -
Bloom EL, Minami H, Brown RA, Strong DR, Riebe D, Abrantes AM. Quality of life after quitting smoking and initiating aerobic exercise. Psychol Health Med. 2017 Oct;22(9):1127-1135. doi: 10.1080/13548506.2017.1282159. Epub 2017 Jan 19. PMID: 28103704; PMCID: PMC5624525.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624525/pdf/nihms899024.pdf -
Jia H, Zack MM, Gottesman II, Thompson WW. Associations of Smoking, Physical Inactivity, Heavy Drinking, and Obesity with Quality-Adjusted Life Expectancy among US Adults with Depression. Value Health. 2018 Mar;21(3):364-371. doi: 10.1016/j.jval.2017.08.002. Epub 2017 Oct 18. PMID: 29566844.
https://www.valueinhealthjournal.com/action/showPdf?pii=S1098-3015%2817%2930335-2 -
Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD001292. doi: 10.1002/14651858.CD001292.pub3. PMID: 28361496; PMCID: PMC6464359.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001292.pub3/epdf/full -
Schlam TR, Baker TB. Interventions for tobacco smoking. Annu Rev Clin Psychol. 2013;9:675-702. doi: 10.1146/annurev-clinpsy-050212-185602. Epub 2013 Jan 3. PMID: 23297788; PMCID: PMC5844577.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844577/pdf/nihms905752.pdf -
Lindson‐Hawley N, Thompson TP, Begh R. Motivational interviewing for smoking cessation. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD006936. DOI: 10.1002/14651858.CD006936.pub3.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006936.pub3/epdf/full -
García-Gómez L, Hernández-Pérez A, Noé-Díaz V, Riesco-Miranda JA, Jiménez-Ruiz C. SMOKING CESSATION TREATMENTS: CURRENT PSYCHOLOGICAL AND PHARMACOLOGICAL OPTIONS. Rev Invest Clin. 2019;71(1):7-16. doi: 10.24875/RIC.18002629. PMID: 30810545.
https://clinicalandtranslationalinvestigation.com/files/ric_71_1_07-16.pdf -
Alboksmaty A, Agaku IT, Odani S, Filippidis FT. Prevalence and determinants of cigarette smoking relapse among US adult smokers: a longitudinal study. BMJ Open. 2019 Nov 25;9(11):e031676. doi: 10.1136/bmjopen-2019-031676. PMID: 31772095; PMCID: PMC6886963.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6886963/pdf/bmjopen-2019-031676.pdf -
Yong HH, Borland R, Cummings KM, Partos T. Do predictors of smoking relapse change as a function of duration of abstinence? Findings from the United States, Canada, United Kingdom and Australia. Addiction. 2018 Jul;113(7):1295-1304. doi: 10.1111/add.14182. Epub 2018 Mar 2. PMID: 29405520; PMCID: PMC5993599.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993599/pdf/nihms940029.pdf -
Quisenberry AJ, Pittman J, Goodwin RD, Bickel WK, D'Urso G, Sheffer CE. Smoking relapse risk is increased among individuals in recovery. Drug Alcohol Depend. 2019 Sep 1;202:93-103. doi: 10.1016/j.drugalcdep.2019.07.001. Epub 2019 Jul 8. PMID: 31325822; PMCID: PMC6685745.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685745/pdf/nihms-1535012.pdf -
Kumar R, Prasad R. Smoking cessation: an update. Indian J Chest Dis Allied Sci. 2014 Jul-Sep;56(3):161-9. PMID: 25823111
https://pubmed.ncbi.nlm.nih.gov/25823111/ -
Miglin R, Kable JW, Bowers ME, Ashare RL. Withdrawal-Related Changes in Delay Discounting Predict Short-Term Smoking Abstinence. Nicotine Tob Res. 2017 Jun 1;19(6):694-702. doi: 10.1093/ntr/ntw246. PMID: 28486708; PMCID: PMC5423100.
https://academic.oup.com/ntr/article-abstract/19/6/694/3805460?redirectedFrom=fulltext -
Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020 Jul;12(7):3866-3876. doi: 10.21037/jtd.2020.02.47. PMID: 32802468; PMCID: PMC7399440.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399440/pdf/jtd-12-07-3866.pdf -
Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009;(192):29-60. doi: 10.1007/978-3-540-69248-5_2. PMID: 19184645; PMCID: PMC2953858.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2953858/pdf/nihms235126.pdf -
Chéruel F, Jarlier M, Sancho-Garnier H. Effect of cigarette smoke on gustatory sensitivity, evaluation of the deficit and of the recovery time-course after smoking cessation. Tob Induc Dis. 2017 Feb 28;15:15. doi: 10.1186/s12971-017-0120-4. PMID: 28261024; PMCID: PMC5329949.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329949/pdf/12971_2017_Article_120.pdf -
Pezzuto A, Stellato M, Catania G, Mazzara C, Tonini S, Caricato M, Crucitti P, Tonini G. Short-term benefit of smoking cessation along with glycopirronium on lung function and respiratory symptoms in mild COPD patients: a retrospective study. J Breath Res. 2018 Aug 6;12(4):046007. doi: 10.1088/1752-7163/aad0a8. PMID: 29967309.
https://pubmed.ncbi.nlm.nih.gov/29967309/ -
Ueha R, Ueha S, Kondo K, Nishijima H, Yamasoba T. Effects of Cigarette Smoke on the Nasal Respiratory and Olfactory Mucosa in Allergic Rhinitis Mice. Front Neurosci. 2020 Feb 18;14:126. doi: 10.3389/fnins.2020.00126. PMID: 32132898; PMCID: PMC7040099.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040099/pdf/fnins-14-00126.pdf -
Purani H, Friedrichsen S, Allen AM. Sleep quality in cigarette smokers: Associations with smoking-related outcomes and exercise. Addict Behav. 2019 Mar;90:71-76. doi: 10.1016/j.addbeh.2018.10.023. Epub 2018 Oct 17. PMID: 30368021; PMCID: PMC6324958.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324958/pdf/nihms-1510780.pdf -
Luna-Perejon F, Malwade S, Styliadis C, Civit J, Cascado-Caballero D, Konstantinidis E, Abdul SS, Bamidis PD, Civit A, Li YJ. Evaluation of user satisfaction and usability of a mobile app for smoking cessation. Comput Methods Programs Biomed. 2019 Dec;182:105042. doi: 10.1016/j.cmpb.2019.105042. Epub 2019 Aug 23. PMID: 31473444.
https://reader.elsevier.com/reader/sd/pii/S016926071831842X?token=E13C584FC8461C0013EC3E120AC59F002AE5BEEA88DB30229A585CE9064F330B2206215D5C65CC12989D7C1D7171C9B4 -
Byeon H, Cha S. Evaluating the effects of smoking on the voice and subjective voice problems using a meta-analysis approach. Sci Rep. 2020 Mar 13;10(1):4720. doi: 10.1038/s41598-020-61565-3. PMID: 32170174; PMCID: PMC7069957.
https://www.nature.com/articles/s41598-020-61565-3 -
Etter JF. Short-term change in self-reported COPD symptoms after smoking cessation in an internet sample. Eur Respir J. 2010 Jun;35(6):1249-55. doi: 10.1183/09031936.00090509. Epub 2009 Nov 19. PMID: 19926745.
https://erj.ersjournals.com/content/35/6/1249.long -
Sveikata K, Balciuniene I, Tutkuviene J. Factors influencing face aging. Literature review. Stomatologija. 2011;13(4):113-6. PMID: 22362337.
https://sbdmj.lsmuni.lt/114/114-02.pdf -
Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004 Mar;23(3):464-76. doi: 10.1183/09031936.04.00012704. PMID: 15065840.
https://erj.ersjournals.com/content/23/3/464.long -
Yu G, Phillips S, Gail MH, Goedert JJ, Humphrys MS, Ravel J, Ren Y, Caporaso NE. The effect of cigarette smoking on the oral and nasal microbiota. Microbiome. 2017 Jan 17;5(1):3. doi: 10.1186/s40168-016-0226-6. PMID: 28095925; PMCID: PMC5240432.
https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-016-0226-6 -
Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, Sellers TA. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol. 2003 Mar 1;21(5):921-6. doi: 10.1200/JCO.2003.05.085. PMID: 12610194.
https://ascopubs.org/doi/10.1200/JCO.2003.05.085?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed& -
Streppel MT, Boshuizen HC, Ocké MC, Kok FJ, Kromhout D. Mortality and life expectancy in relation to long-term cigarette, cigar and pipe smoking: the Zutphen Study. Tob Control. 2007 Apr;16(2):107-13. doi: 10.1136/tc.2006.017715. PMID: 17400948; PMCID: PMC2598467.
https://tobaccocontrol.bmj.com/content/16/2/107.long -
Heckman BW, Cummings KM, Stoltman JJK, Dahne J, Borland R, Fong GT, Carpenter MJ. Longer duration of smoking abstinence is associated with waning cessation fatigue. Behav Res Ther. 2019 Apr;115:12-18. doi: 10.1016/j.brat.2018.11.011. Epub 2018 Nov 23. PMID: 30509485; PMCID: PMC6409126.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409126/pdf/nihms-1515544.pdf -
Establishment of a multimodal protocol combining a motivational interview, subcutaneous injection of NicoSan® and hyper-hydration for the "stopsmoking therapy": A multicentre real-life study
https://pubmed.ncbi.nlm.nih.gov/34148643/
Il vous reste une dernière étape pour valider définitivement votre rendez-vous et recevoir votre convocation médicale.
Prenez quelques instants pour remplir attentivement votre questionnaire médical. Celui-ci est nécessaire au bon déroulement de vos soins